---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-23-003236"
form_type: "8-K"
ticker: "MCAG"
cik: "0001859035"
company_name: "Mountain Crest Acquisition Corp. V"
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T07:07:53.250218+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Mountain Crest V furnishes investor presentation for AUM deal; no new material info

## Summary
- SPAC entered business combination agreement with AUM Biosciences on Oct 19, 2022, amended multiple times through April 19, 2023.
- Exhibit 99.1 is a form investor presentation used for management meetings; no new specific financial data or guidance disclosed.
- Presentation includes standard forward-looking statements and risk factors typical for pre-clinical biotech SPAC deals.
- Holdco has filed an F-4 registration statement with SEC; stockholders urged to read proxy statement/prospectus when available.

## SEC filing metadata
- accession: 0001829126-23-003236
- form_type: 8-K
- ticker: MCAG
- cik: 0001859035
- company_name: Mountain Crest Acquisition Corp. V
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859035/000182912623003236/0001829126-23-003236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859035/000182912623003236/mountaincrest5_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-23-003236
- JSON: https://secwatch.observer/filing/0001829126-23-003236.json
- Plain text: https://secwatch.observer/filing/0001829126-23-003236.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.